Quest Diagnostics Q3 FY2026: revenue up 10.0%, adjusted EPS $3.00, guidance raised
Quest Diagnostics delivered a volume-led quarter, beat the $2.89 consensus on adjusted EPS with $3.00, and raised full-year revenue and EPS guidance — a Bullish read on the operating business. Revenue of $3.10 billion rose 10.0%, though the mix is telling: requisitions up 14.5%, revenue per requisition down 4.2%. GAAP EPS of $2.78 landed below consensus, so the quality of the beat depends on how you treat $0.24 of amortization.
1 · Expected vs. Actual
Free preview belowGAAP diluted EPS of $2.78 was up 28.7% year over year but below the $2.89 consensus figure. Adjusted EPS of $3.00 cleared that consensus by about $0.11, and the $0.22 gap between the two lines is mostly $0.24 of amortization expense. With nine-month adjusted EPS at $8.62, the new $11.25–$11.35 full-year range leaves roughly $2.68 for the fourth quarter.
Revenue of $3.10 billion rose 10.0% from $2.82 billion a year earlier and came in above the $3.04 billion consensus revenue figure provided. All of the growth was volume: requisitions rose 14.5%, of which 14.4% was organic, while revenue per requisition fell 4.2%. Diagnostic Information Services contributed $3.04 billion of the total, with all other segments at $62 million.
Management lifted full-year revenue to $12.065–$12.105 billion from $11.95–$12.05 billion, and adjusted EPS to $11.25–$11.35 from $11.05–$11.25. The $12.085 billion revenue midpoint is $85 million above the prior midpoint, and the $11.30 adjusted EPS midpoint is $0.15 above the prior one. The shape matters: nine months of revenue are $9.035 billion, so the new range implies about $3.05 billion in Q4, slightly below the $3.10 billion just reported.
Log in to read 35 analyses a week for free
Create a free account to read 35 full earnings analyses each week — all five steps: expected vs. actual, guidance tracker, money flow, balance sheet and risks. Members get unlimited access.
Figures on this page come from the company's original SEC filings. The analysis is generated automatically and checked against validation rules, but may still contain errors or omissions. Not investment advice. · Generated 2026-10-23
Answers are based on the earnings release and the analysis above. Free accounts get 3 questions a week; members get 30 a day.